Biotech FDA grants Medivir´s MIV-711 Rare Pediatric Disease Designation and Orphan Drug Designation for the treatment of Legg-Calvé-Perthes Disease April 25, 2024
Biotech Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors April 24, 2024
Biotech Zealand Pharma Partners with Benchling to Advance R&D of Engineered Peptide Medicines April 23, 2024
Biotech Medivir provides update from supportive Type C meeting with the FDA; preparations for enhanced phase 2b in HCC with fostrox + Lenvima continue April 23, 2024
Biotech AMSilk strengthens management team with key hires of Ralph Fraundorfer and Ctibor Kohutovic to Management Board April 23, 2024
Biotech HanxBio announces the publication of a research paper in Scientific Reports on preclinical evaluation of Narazaciclib for the treatment of acute myeloid leukemia (AML) April 23, 2024
Search
Biotech
April 25, 2024
April 25, 2024
April 24, 2024
April 24, 2024
April 24, 2024
April 24, 2024
April 23, 2024
April 23, 2024
April 23, 2024
April 23, 2024
